Ring Finger Protein 213 Variant and Plaque Characteristics, Vascular Remodeling, and Hemodynamics in Patients With Intracranial Atherosclerotic Stroke: A High‐Resolution Magnetic Resonance Imaging and Hemodynamic Study
暂无分享,去创建一个
Yoon-Chul Kim | C. Ki | Gyeong-Moon Kim | O. Bang | W. Seo | Jong-Won Chung | Eun‐Hyeok Choi | Hanul Lee
[1] Maheshwari Patel,et al. Study , 2019, Definitions.
[2] Seung-Chyul Hong,et al. Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease , 2018, Stroke.
[3] Gyeong-Moon Kim,et al. Outcomes after ischemic stroke caused by intracranial atherosclerosis vs dissection , 2018, Neurology.
[4] Andrew D. Johnson,et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.
[5] Andrew D. Johnson,et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.
[6] C. Ki,et al. Nonsyndromic Peripheral Pulmonary Artery Stenosis Is Associated With Homozygosity of RNF213 p.Arg4810Lys Regardless of Co‐occurrence of Moyamoya Disease , 2017, Chest.
[7] Gyeong-Moon Kim,et al. Arterial Dissection as a Cause of Intracranial Stenosis in East Asians. , 2017, Journal of the American College of Cardiology.
[8] Seung-Chyul Hong,et al. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease , 2017, PloS one.
[9] H. Mori,et al. Smaller outer diameter of atherosclerotic middle cerebral artery associated with RNF213 c.14576G>A Variant (rs112735431) , 2017, Surgical neurology international.
[10] Hyun Ah Choi,et al. Abstract 110: Caveolin-1 and Arterial Remodeling in Adult Moyamoya Disease , 2017 .
[11] K. Kosaki,et al. Homozygosity for moyamoya disease risk allele leads to moyamoya disease with extracranial systemic and pulmonary vasculopathy , 2016, American journal of medical genetics. Part A.
[12] J. Cha,et al. Previous Statin Use and High-Resolution Magnetic Resonance Imaging Characteristics of Intracranial Atherosclerotic Plaque: The Intensive Statin Treatment in Acute Ischemic Stroke Patients With Intracranial Atherosclerosis Study , 2016, Stroke.
[13] Seung-Chyul Hong,et al. A Polymorphism in RNF213 Is a Susceptibility Gene for Intracranial Atherosclerosis , 2016, PloS one.
[14] Seung-Chyul Hong,et al. Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease , 2016, International journal of stroke : official journal of the International Stroke Society.
[15] M. Fujimura,et al. The Pathophysiology of Moyamoya Disease: An Update , 2016, Journal of stroke.
[16] A. Koizumi,et al. A new horizon of moyamoya disease and associated health risks explored through RNF213 , 2015, Environmental Health and Preventive Medicine.
[17] J. Cha,et al. Differential Vascular Pathophysiologic Types of Intracranial Atherosclerotic Stroke: A High-Resolution Wall Magnetic Resonance Imaging Study , 2015, Stroke.
[18] Seung-Chyul Hong,et al. Adult Moyamoya Disease: A Burden of Intracranial Stenosis in East Asians? , 2015, PloS one.
[19] E. Feldmann,et al. Noninvasive Fractional Flow on MRA Predicts Stroke Risk of Intracranial Stenosis , 2015, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[20] Gao T. Wang,et al. RNF213 Rare Variants in an Ethnically Diverse Population With Moyamoya Disease , 2014, Stroke.
[21] Seung-Chyul Hong,et al. High-Resolution Magnetic Resonance Wall Imaging Findings of Moyamoya Disease , 2014, Stroke.
[22] T. Tominaga,et al. Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene , 2014, Journal of stroke.
[23] W. Park,et al. Smooth-muscle progenitor cells isolated from patients with moyamoya disease: novel experimental cell model. , 2014, Journal of neurosurgery.
[24] O. Bang. Intracranial Atherosclerosis: Current Understanding and Perspectives , 2014, Journal of stroke.
[25] E. Feldmann,et al. Signal Intensity Ratio as a Novel Measure of Hemodynamic Significance for Intracranial Atherosclerosis , 2013, International journal of stroke : official journal of the International Stroke Society.
[26] A. Mukasa,et al. Genetic Variant RNF213 c.14576G>A in Various Phenotypes of Intracranial Major Artery Stenosis/Occlusion , 2013, Stroke.
[27] K. Nakao,et al. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. , 2013, Biochemical and biophysical research communications.
[28] Lu Ma,et al. RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis. , 2013, Neurology India.
[29] S. Nanayakkara,et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure , 2013, Environmental Health and Preventive Medicine.
[30] A. Mukasa,et al. Identification of a Genetic Variant Common to Moyamoya Disease and Intracranial Major Artery Stenosis/Occlusion , 2012, Stroke.
[31] C. Sudlow,et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies , 2012, The Lancet Neurology.
[32] M. Guan,et al. Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population , 2012, PloS one.
[33] A. Koizumi,et al. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. , 2012, Neurologia medico-chirurgica.
[34] H. Steinmetz,et al. Critique of "Stenting versus aggressive medical therapy for intracranial arterial stenosis" by Chimowitz et al in the new England Journal of Medicine. , 2012, Stroke.
[35] A. Fujiyama,et al. Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development , 2011, PloS one.
[36] A. Hata,et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene , 2011, Journal of Human Genetics.
[37] H. Dvorak,et al. Vascular permeability and pathological angiogenesis in caveolin-1-null mice. , 2009, The American journal of pathology.
[38] D. Liebeskind,et al. Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: Data from a diverse race-ethnic group , 2009, Journal of the Neurological Sciences.
[39] 吉井 信夫. Spontaneous occlusion of the circle of willis : moyamoya disease , 2009 .
[40] J. Roh,et al. Circulating Endothelial Progenitor Cells as a Pathogenetic Marker of Moyamoya Disease , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[41] R. Sacco,et al. Metabolic Syndrome and Ischemic Stroke Risk: Northern Manhattan Study , 2008, Stroke.
[42] N. Forouhi,et al. CVD risk factors and ethnicity--a homogeneous relationship? , 2006, Atherosclerosis. Supplements.
[43] S. Kasner,et al. Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis , 2006, Circulation.
[44] S. Ho,et al. A possible explanation for the racial difference in distribution of large-arterial cerebrovascular disease: ancestral European settlers evolved genetic resistance to atherosclerosis, but confined to the intracranial arteries. , 2005, Medical hypotheses.
[45] David S. Park,et al. Caveolin, Caveolae, and Endothelial Cell Function , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[46] David S. Park,et al. Caveolin-1 Expression Enhances Endothelial Capillary Tubule Formation* , 2002, The Journal of Biological Chemistry.
[47] M. Fukui. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. , 1997, Clinical neurology and neurosurgery.
[48] M. Weiss,et al. Effect of coronary artery size on the prevalence of atherosclerosis. , 1996, The American journal of cardiology.
[49] R. Sacco,et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. , 1995, Stroke.